Kathrin Hartmann Selected Research

hexadecyloxypropyl cytarabine 5'-monophosphate

1/2012

A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathrin Hartmann Research Topics

Disease

2	Autism Spectrum Disorder 01/2015 - 05/2014
2	Hypertension (High Blood Pressure) 07/2011 - 07/2006
1	Optic Neuritis (Retrobulbar Neuritis) 03/2016
1	Epiretinal Membrane (Epiretinal Membranes) 04/2012
1	Proliferative Vitreoretinopathy 01/2012
1	Toxic Optic Neuropathy 01/2012
1	Retinitis 12/2011
1	Diabetes Mellitus 07/2011
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2011
1	Macular Edema 06/2011
1	Burns 06/2011
1	Microaneurysm 06/2011
1	Thrombophilia 01/2006

Drug/Important Bio-Agent (IBA)

4	Retinaldehyde (Retinal)IBA 03/2016 - 06/2011
2	Cycloserine (Seromycin)FDA Link 01/2015 - 05/2014
2	ProdrugsIBA 01/2012 - 12/2011
1	Erythropoietin FDA Link 03/2016
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2015
1	N-Methylaspartate (NMDA)IBA 01/2015
1	hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphateIBA 01/2012
1	LipidsIBA 01/2012
1	hexadecyloxypropyl cytarabine 5'-monophosphateIBA 01/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012
1	brincidofovirIBA 12/2011
1	Cidofovir (Vistide)FDA Link 12/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2006
1	Prothrombin (Factor II)IBA 01/2006
1	Messenger RNA (mRNA)IBA 01/2006

Therapy/Procedure

1	Lasers (Laser) 06/2011
1	Aftercare (After-Treatment) 06/2011
1	Light Coagulation 06/2011